IMPACT OF BACTERIAL INFECTIONS IN PERITONEAL DIALYSIS PATIENTS

M NAJUMUSAQIB; . ZAINAB; H ULLAH; A SALMAN; M SABEREEN; F BANARAS

doi:10.54112/bcsrj.v2023i1.437

Authors

M NAJUMUSAQIB Department of Nephrology, Khyber Teaching Hospital, Peshawar, Pakistan
. ZAINAB Department of Pathology, Bacha Khan Medical College-BKMC/MMC-MTI, Mardan, Pakistan
H ULLAH Department of Nephrology, Jinnah Medical College and Teaching Hospital, Peshawar
A SALMAN Department of Nephrology, Khyber Teaching Hospital, Peshawar, Pakistan
M SABEREEN Department of Nephrology, Khyber Teaching Hospital, Peshawar, Pakistan
F BANARAS Department of Nephrology, Khyber Teaching Hospital, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.437

Keywords:

Antibiotic resistance; Bacterial infections; Pseudomonas aeruginosa; Staphylococcus aureus; Peritoneal Dialysis; Treatment strategies

Abstract

Bacterial infections can cause significant clinical complications in patients undergoing Peritoneal Dialysis (PD). This study aimed to determine bacterial infection's clinical and psychosocial outcomes in PD patients. A prospective observational study enrolled 150 PD patients through non-probability sequential sampling. Demographic information, duration of PD, previous infections, and laboratory results were collected. Bacterial infections were identified through routine cultures of PD fluids, and antibiotic susceptibility was determined using the disc diffusion method. The average age of PD patients was 52.3 years, with 42% men and 58% women (p<0.05). Staphylococcus aureus infected 22 patients (14.67%), whereas Streptococci infected 18 patients (12%) (p<0.05). Antibiotic susceptibility assays determined that Staphylococcus aureus was 77% sensitive to vancomycin. Seventy-five patients (50%) on PD for more than 19 months encountered infections. Among the infected group, 90 patients (60%) recovered without complications, while 5 (4.2%) died. The study revealed a significant correlation between bacterial infections in PD patients and clinical symptoms, antibiotic resistance patterns, and disease duration. These findings highlight the importance of enhanced patient monitoring and evolving treatment strategies to improve patient outcomes.

Downloads

Download data is not yet available.

References

Akoh, J. A. (2012). Peritoneal dialysis associated infections: an update on diagnosis and management. World journal of nephrology 1, 106.

Ali, A. A., Sharif, D. A., Almukhtar, S. E., Abd, K. H., Saleem, Z. S. M., and Hughson, M. D. (2018). Incidence of glomerulonephritis and non-diabetic end-stage renal disease in a developing middle-east region near armed conflict. BMC nephrology 19, 1-9.

Blake, P. G. (2001). Integrated end‐stage renal disease care: the role of peritoneal dialysis. Nephrology Dialysis Transplantation 16, 61-66.

Brito, D. C. S. d., Machado, E. L., Reis, I. A., Carmo, L. P. d. F. d., and Cherchiglia, M. L. (2019). Depression and anxiety among patients undergoing dialysis and kidney transplantation: a cross-sectional study. Sao Paulo Medical Journal 137, 137-147.

Curty, N. F. R., Martins, L. F. d. S., Ito, C. A. S., Schafranski, M., Brites, D. A., and Busato, C. R. (2014). Morbimortality study of infection in patients undergoing different types of dialysis in a renal replacement therapy center. Brazilian Journal of Infectious Diseases 18, 281-286.

François, K., and Bargman, J. M. (2014). Evaluating the benefits of home-based peritoneal dialysis. International journal of nephrology and renovascular disease, 447-455.

Halle, M. P., Takongue, C., Kengne, A. P., Kaze, F. F., and Ngu, K. B. (2015). Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC nephrology 16, 1-8.

Kazi, A. M., and Hashmi, M. F. (2020). Glomerulonephritis.

Kendir, C., van den Akker, M., Vos, R., and Metsemakers, J. (2018). Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands. European Journal of General Practice 24, 45-50.

Nguyen, D. B., Arduino, M. J., and Patel, P. R. (2019). Hemodialysis-associated infections. Chronic kidney disease, dialysis, and transplantation, 389.

Onwubiko, N. E., and Sadiq, N. M. (2011). Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan African Medical Journal 8.

Osório, N., Oliveira, V., Costa, M. I., Santos-Costa, P., Serambeque, B., Gama, F., Adriano, D., Graveto, J., Parreira, P., and Salgueiro-Oliveira, A. (2023). Short Peripheral Venous Catheters Contamination and the Dangers of Bloodstream Infection in Portugal: An Analytic Study. Microorganisms 11, 709.

Poulsen, H. B., á Steig, T., Björkman, J. T., and Gaini, S. (2018). Peritonitis with Listeria monocytogenes in a patient on automated peritoneal dialysis. Case Reports 2018, bcr-2017-220088.

Qureshi, M., Rashid, S., Qamar, M., Moon, F., Danial, K., and Abid, K. (2023). Causes of Mortality in End Stage Renal Disease Patients in a Single Haemodialysis Center. Life and Science 4, 5-5.

Sartelli, M., Catena, F., Abu-Zidan, F. M., Ansaloni, L., Biffl, W. L., Boermeester, M. A., Ceresoli, M., Chiara, O., Coccolini, F., and De Waele, J. J. (2017). Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World journal of emergency surgery 12, 1-31.

Scheuch, M., Freiin von Rheinbaben, S., Kabisch, A., Engeßer, J., Ahrendt, S., Dabers, T., Kohler, C., Holtfreter, S., Bröker, B. M., and Stracke, S. (2019). Staphylococcus aureus colonization in hemodialysis patients: a prospective 25 months observational study. BMC nephrology 20, 1-12.

Shariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., and Khoshnood, S. (2022). The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in Public Health 10, 1025633.

Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L., and Fowler Jr, V. G. (2015). Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical microbiology reviews 28, 603-661.

Wang, H.-H., Huang, C.-H., Kuo, M.-C., Lin, S.-Y., Hsu, C.-H., Lee, C.-Y., Chiu, Y.-W., Chen, Y.-H., and Lu, P.-L. (2019). Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan. Journal of Microbiology, Immunology and Infection 52, 752-759.

Yung, S., and Chan, T. M. (2012). Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators of inflammation 2012.